HOME >> BIOLOGY >> NEWS
Vertex Pharmaceuticals/Yale Research Team Uses Gene Knockout Mice To Establish Role Of Caspase-9 In Neuronal Cell Death Pathway

Cambridge, MA, August 7, 1998 -- A team of scientists from Vertex Pharmaceuticals, Yale University School of Medicine, Howard Hughes Medical Institute (HHMI) at Yale University, and Tokyo Metropolitan Institute of Medical Science (TMI) reported results with a gene knockout mouse that establishes a key role for the enzyme Caspase-9 in a specific biochemical pathway that results in neuronal cell death. These findings, published in the August 7, 1998 issue of Cell, suggest that blocking Caspase-9 may be a viable strategy for treating a variety of acute and chronic age-related neurological diseases, including Alzheimer's disease, Parkinson's disease and stroke.

Caspases comprise a family of enzymes that are being evaluated for their role in a number of diseases, based on their involvement in biochemical pathways of inflammation and of apoptosis (also known as programmed cell death or cell suicide). Apoptosis is an essential component of numerous biological processes, including tissue remodeling, immune system regulation and embryonic development. Abnormal activation of apoptosis, however, is implicated in the development and progression of a number of different human diseases, and links between specific caspases and specific diseases are beginning to be established. The publication of the Cell paper is the first report describing the in vivo function of Caspase-9, and suggests apparent tissue-selective activity among the eleven reported human caspases.

"When mitochondria -- the energy factory of cells -- are damaged, Caspase-9 is activated leading to cell death," said Dr. Richard A Flavell, an HHMI Investigator and an author of the study. "In cells lacking Caspase-9, this damage did not give rise to cell death."

"Our results also indicate that Caspase-9 is activated early and is essential for apoptosis in neuronal cells, and that deletion of Caspase-9 does not interfere with embryonic development of other non-neuronal tissues," said Dr. Keisuke Kuida, St
'"/>

Contact: Michael Partridge
partridge@vpharm.com
(617) 577-6108
Vertex Pharmaceuticals
7-Aug-1998


Page: 1 2 3 4

Related biology news :

1. Research Findings Suggest Potent, Broad-Spectrum Antiviral Activity For Vertexs Investigational IMPDH Inhibitor VX-497
2. Phase III Results Suggest Potent Antiviral Activity For Vertex And Glaxo Wellcomes Second-Generation HIV Protease Inhibitor Agenerase TM
3. Vertex Researchers Report Three-Dimensional Atomic Structure Of JNK3 Enzyme; Report In Structure
4. Vertex Pharmaceuticals Researchers Report Three-Dimensional Structure Of Hepatitis C Helicase Enzyme; Report In Structure
5. Researchers determine genetic cause of Timothy syndrome
6. Researchers find color sensitive atomic switch in bacteria
7. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
8. Researchers identify protein promoting vascular tumor growth
9. Researchers devise potent new tools to curb ivory poaching
10. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
11. Researchers ID chlorophyll-regulating gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... October 02, 2018 , ... Stem Cell Innovations (SCI), a global ... to stem cell therapy, has launched the pre-sale for their ICO with ... platform that will connect patients and stem cell specialists around the world. ...
(Date:10/2/2018)... ... October 02, 2018 , ... Through this webinar, sponsored by Molecular Devices ... also learn the role of calcium kinetics in cardiac safety testing. The speakers for ... PPSC Biography; and Tsang Wai Lam, an assay development scientist at PPSC. , They ...
(Date:10/2/2018)... ... October 02, 2018 , ... As a leading innovator ... The Cell Analysis Company , is excited to offer xCELLigence® RTCA Software ... and data analysis for immune oncology researchers are now much easier, especially when ...
Breaking Biology News(10 mins):
(Date:10/2/2018)... Switzerland (PRWEB) , ... October ... ... provider of advanced software solutions for biopharmaceutical R&D, today announced a new ... mini-bioreactor systems from Sartorius, a leading international pharmaceutical and laboratory equipment supplier. ...
(Date:10/2/2018)... Mass. (PRWEB) , ... October 02, 2018 , ... ... ACRES ) announced this week that teams have initiated validation of standards and ... effort, under the direction of Dr. Larry Kennedy, ACRES VP for Quality Management ...
(Date:9/28/2018)... ... September 28, 2018 , ... LabRoots , ... and scientists from around the world, is excited to announce Daniel Andrade, a ... as the winner of the LabRoots Summer 2018 Textbook Scholarship, awarding him $1,000 ...
(Date:9/27/2018)... ... September 26, 2018 , ... Medable was named ... to build the first human digitome, a digital representation of human health and ... seamless integration of all data sources. Dr. Michelle Longmire, Co-Founder and CEO of ...
Breaking Biology Technology:
Cached News: